1,131
Participants
Start Date
September 24, 2020
Primary Completion Date
August 29, 2024
Study Completion Date
August 29, 2024
Tolebrutinib
Pharmaceutical form: Film-coated tablet Route of administration: Oral
Placebo to match Tolebrutinib
Pharmaceutical form: Film-coated tablet Route of administration: Oral
Investigational Site Number :0320002, Capital Federal
Investigational Site Number : 0560009, Brussels
Investigational Site Number :0400002, Vienna
Investigational Site Number :1000004, Sofia
Investigational Site Number :3480008, Budapest
Investigational Site Number :3480004, Budapest
Investigational Site Number :3480007, Budapest
Investigational Site Number :0560007, Brussels
Investigational Site Number :1000008, Sofia
Investigational Site Number :1000001, Sofia
Investigational Site Number :1000006, Sofia
Investigational Site Number :1000009, Sofia
Investigational Site Number :0320007, Buenos Aires
Investigational Site Number : 0360007, St Leonards
Investigational Site Number :3480006, Tatabánya
Investigational Site Number :0560006, Leuven
Investigational Site Number :0360001, Fitzroy
Investigational Site Number :0360006, Heidelberg West
Investigational Site Number :0560001, Overpelt
Investigational Site Number :0560008, Liège
Investigational Site Number :1000005, Plovdiv
Investigational Site Number :0400001, Linz
Investigational Site Number :0400004, Linz
Investigational Site Number :0360003, Woolloongabba
Investigational Site Number :0320006, Córdoba
Investigational Site Number :2080004, Odense
Investigational Site Number :5780003, Bergen
Investigational Site Number :1000002, Pleven
Investigational Site Number :0400003, Innsbruck
Investigational Site Number :2080001, Esbjerg
Investigational Site Number :3480001, Szeged
Investigational Site Number :0560002, Mons
Investigational Site Number :0360004, Hobart
Investigational Site Number :2080005, Holstebro
Investigational Site Number :3480002, Pécs
Investigational Site Number :5780002, Namsos
Investigational Site Number : 0560004, Ghent
Investigational Site Number :8040014, Zhytomyr
Investigational Site Number :2760009, Berlin
Investigational Site Number :3000006, Athens
Neurology Associates of Stony Brook-Site Number:8400042, Stony Brook
Investigational Site Number :3000002, Athens
Investigational Site Number :2030005, Prague
Investigational Site Number :3760004, Safed
Investigational Site Number :7240008, Córdoba
Investigational Site Number :3000007, Athens
Investigational Site Number :3800014, Genova
Investigational Site Number :7240014, Salt
Investigational Site Number :2760004, Rostock
Perelman Center for Advanced Medicine-Site Number:8400142, Philadelphia
Jefferson Neurology Associates-Site Number:8400016, Philadelphia
Investigational Site Number :7240012, Donostia / San Sebastian
Investigational Site Number :3800004, Milan
Investigational Site Number :3800001, Milan
Investigational Site Number :3800010, Milan
Investigational Site Number :2460002, Turku
Investigational Site Number :8040006, Vinnytsia
Investigational Site Number :3800011, Bergamo
Investigational Site Number :7240015, Lleida
Investigational Site Number :3800008, Pavia
Meridian Clinical Research, LLC-Site Number:8400005, Raleigh
Investigational Site Number :7240005, Madrid
Investigational Site Number :7240002, Madrid
Investigational Site Number :7240003, Madrid
Investigational Site Number :7240004, Majadahonda
Investigational Site Number :7240001, Pozuelo de Alarcón
Investigational Site Number :7240009, Málaga
Premier Neurology-Site Number:8400069, Greer
Investigational Site Number :2500017, Nîmes
Investigational Site Number :7240010, Murcia
Investigational Site Number :2760006, Hanover
Investigational Site Number :2500012, Toulouse
Investigational Site Number :3760003, Haifa
Meridian Clinical Research-Site Number:8400003, Savannah
Neurology Associates, PA-Site Number:8400004, Maitland
Investigational Site Number :7920012, Mersin
South Florida Neurology Associates-Site Number:8400029, Boca Raton
Investigational Site Number :2460001, Tampere
University of South Florida-Site Number:8400006, Tampa
Investigational Site Number :7920002, Istanbul
Aqualane Clinical Research-Site Number:8400027, Naples
Investigational Site Number :2500006, Montpellier
Investigational Site Number :7920009, Istanbul
Investigational Site Number :7920007, Istanbul
Investigational Site Number :7920006, Istanbul
Investigational Site Number :7240017, Las Palmas de Gran Canaria
Investigational Site Number :2500003, Rennes
Investigational Site Number :7920013, Izmir
University of Alabama MS Center-Site Number:8400013, Birmingham
Investigational Site Number :2760002, Giessen
Advanced Neuroscience Center-Site Number:8400035, Franklin
Neurology Clinic, PC-Site Number:8400087, Cordova
Columbus Neuroscience-Site Number:8400010, Westerville
CHI Saint Joseph Medical Group Neurology-Site Number:8400110, Lexington
Investigational Site Number :7240007, Seville
Investigational Site Number :3000004, Larissa
Investigational Site Number :7920001, İzmit
Investigational Site Number :8040005, Lutsk
Investigational Site Number :7920011, Kütahya
Optimed Research, LTD-Site Number:8400147, Columbus
Investigational Site Number :2500010, Nantes
University Hospitals CMC-Site Number:8400083, Cleveland
Cleveland Clinic-Site Number:8400125, Cleveland
Investigational Site Number :2760012, Essen
Neurology Specialists-Site Number:8400002, Dayton
Investigational Site Number :7240011, Valencia
Investigational Site Number :2760008, Münster
Wayne State University-Site Number:8400046, Detroit
The Memorial Hospital-Site Number:8400033, Owosso
Investigational Site Number :8040003, Dnipro
Investigational Site Number :2030004, Hradec Králové
Investigational Site Number :3800012, Florence
Investigational Site Number :3800016, Florence
Investigational Site Number :4400003, Kaunas
Investigational Site Number :3760001, Tel Litwinsky
Medical College of Wisconsin-Site Number:8400028, Milwaukee
Investigational Site Number :2500008, Nancy
Minneapolis Clinic of Neurology-Site Number:8400051, Minneapolis
Mayo Clinic-Site Number:8400111, Rochester
Investigational Site Number :3000005, Thessaloniki
Investigational Site Number :8040008, Chernivtsi
Investigational Site Number :8040016, Chernivtsi
Sanford Brain & Spine Center-Site Number:8400126, Fargo
Investigational Site Number :2030001, Jihlava
Investigational Site Number :2500009, Lille
Consultants In Neurology-Site Number:8400011, Northbrook
Investigational Site Number :8040007, Kharkiv
Investigational Site Number :7920008, Trabzon
Investigational Site Number :8040011, Kharkiv
Investigational Site Number :8040012, Kharkiv
Investigational Site Number :2500005, Clermont-Ferrand
Missouri Baptist Medical Center-Site Number:8400019, St Louis
Investigational Site Number :8040002, Odesa
Investigational Site Number :2030002, Brno
Investigational Site Number :3800013, L’Aquila
Investigational Site Number :2500001, Strasbourg
Investigational Site Number :2500011, Bron
Investigational Site Number :2030010, Ostrava - Poruba
Investigational Site Number :2500016, Paris
Investigational Site Number :2500014, Paris
Investigational Site Number :2500007, Paris
Investigational Site Number :8040010, Ivano-Frankivsk
Baylor College of Medicine-Site Number:8400136, Houston
Neurology Center of San Antonio-Site Number:8400036, San Antonio
Investigational Site Number :3760002, Ashkelon
Investigational Site Number :8040009, Lviv
Investigational Site Number :8040004, Lviv
University of Colorado-Site Number:8400012, Denver
Advanced Neurosciences Research-Site Number:8400025, Fort Collins
Mountain Neurological Research Center, Inc.-Site Number:8400128, Basalt
Center for Neurology and Spine-Site Number:8400089, Phoenix
University of New Mexico-Site Number:8400032, Albuquerque
Investigational Site Number :2760011, Ulm
Lou Ruvo Center for Brain Health-Site Number:8400117, Las Vegas
Multiple Sclerosis Center-Site Number:8400143, Los Angeles
Regina Berkovich, MD, PhD-Site Number:8400059, West Hollywood
Harbor UCLA-Site Number:8400088, Torrance
Collaborative Neuroscience Research-Site Number:8400045, Long Beach
Arcadia Neurology Center-Site Number:8400070, Arcadia
Investigational Site Number :3760008, Jerusalem
UC San Diego ACTRI-Site Number:8400101, La Jolla
Investigational Site Number :4400002, Klaipėda
University of San Francisco, Sandler Neurosciences Center-Site Number:8400137, San Francisco
Investigational Site Number :2760005, Bayreuth
Investigational Site Number :2500015, Gonesse
Providence Multiple Sclerosis Center-Site Number:8400020, Portland
Investigational Site Number :1560006, Beijing
Investigational Site Number :1560012, Beijing
Investigational Site Number :1560021, Beijing
Investigational Site Number :1560003, Beijing
Investigational Site Number :1560009, Beijing
Investigational Site Number :3560006, New Delhi
Investigational Site Number :3560002, New Delhi
Investigational Site Number :6420004, Campulung Muscel
Investigational Site Number :6430020, Moscow
Investigational Site Number :3560007, Gūrgaon
Investigational Site Number :3560003, Gūrgaon
Investigational Site Number :6430002, Moscow
Investigational Site Number :6430013, Moscow
Investigational Site Number :6430001, Moscow
Investigational Site Number :6430008, Moscow
Investigational Site Number :1560004, Changchun
Investigational Site Number :6430011, Saint Petersburg
Investigational Site Number :6430004, Saint Petersburg
Investigational Site Number :1120004, Vitebsk
Investigational Site Number :1120005, Vitebsk
Investigational Site Number :6430014, Smolensk
Investigational Site Number :6430025, Kaliningrad
Investigational Site Number :6420002, Timișoara
Investigational Site Number :1560007, Hangzhou
Investigational Site Number :6430016, Rostov-on-Don
Investigational Site Number :1560035, Fuzhou
Investigational Site Number :6430007, Pyatigorsk
Investigational Site Number :6420006, Cluj-Napoca
Investigational Site Number :1560019, Chongqing
Investigational Site Number :1560015, Changsha
Investigational Site Number :6420013, Oradea
Investigational Site Number :6430003, Kazan'
Investigational Site Number :6430019, Saransk
Investigational Site Number : 3560009, Nagpur
Investigational Site Number :6430009, Samara
Investigational Site Number :6430010, Ufa
Investigational Site Number :1560001, Guangzhou
Investigational Site Number :6420001, Târgu Mureş
Investigational Site Number :6420005, Sibiu
Investigational Site Number :3560004, Mangaluru
Investigational Site Number :6430021, Nizhny Novgorod
Investigational Site Number :6430006, Nizhny Novgorod
Investigational Site Number :1560005, Chengdu
Investigational Site Number :6430017, Kirov
Investigational Site Number :6430026, Perm
Investigational Site Number :6430023, Yekaterinburg
Investigational Site Number :6430012, Tyumen
Investigational Site Number :6430005, Novosibirsk
Investigational Site Number :6430022, Kemerovo
Investigational Site Number :6430018, Barnaul
Investigational Site Number :6430024, Krasnoyarsk
Investigational Site Number :1560017, Xi'an
Investigational Site Number :6420003, Constanța
Axiom Clinical Research of Florida-Site Number:8400001, Tampa
University of Kansas Medical Center-Site Number:8400023, Kansas City
Tufts Medical Center-Site Number:8400072, Boston
University of Massachusetts-Site Number:8400014, Worcester
Holy Name Hospital-Site Number:8400104, Teaneck
Icahn School of Medicine at Mount Sinai (Department of Endoc-Site Number:8400038, New York
Mountain View Clinical Research-Site Number:8400024, Greer
University Of Vermont College Of Medicine-Site Number:8400130, Burlington
Investigational Site Number :0320001, CABA
Investigational Site Number :0320005, San Miguel de Tucumán
Investigational Site Number :0360002, Kent Town
Investigational Site Number :3560005, India
Investigational Site Number :7920005, Eskişehir
Investigational Site Number :7920010, Hatay
Investigational Site Number :7920003, Istanbul
Investigational Site Number :0560003, Edegem
Investigational Site Number :1240017, Burnaby
Investigational Site Number :1240011, Halifax
Investigational Site Number :1240003, Ottawa
Investigational Site Number :1240008, Toronto
Investigational Site Number :1240006, Gatineau
Investigational Site Number :1240005, Greenfield Park
Investigational Site Number :1240004, Montreal
Investigational Site Number :1240015, Montreal
Investigational Site Number :1240007, Sherbrooke
Investigational Site Number : 1240001, Québec
Investigational Site Number :1240021, Québec
Investigational Site Number :1560014, Shijiazhuang
Investigational Site Number :1560008, Taiyuan
Investigational Site Number :2030003, Teplice
Investigational Site Number :2460003, Helsinki
Investigational Site Number :2760001, Dresden
Investigational Site Number :2760010, Halle
Investigational Site Number :3000001, Athens
Investigational Site Number :3000003, Thessaloniki
Investigational Site Number :3800007, Cagliari
Investigational Site Number :3800005, Roma
Investigational Site Number :3800009, Roma
Investigational Site Number :3920016, Chiba
Investigational Site Number :3920022, Morioka
Investigational Site Number :3920011, Kyoto
Investigational Site Number :3920020, Sendai
Investigational Site Number :3920005, Niigata
Investigational Site Number :3920004, Moriguchi-shi
Investigational Site Number :3920001, Osaka
Investigational Site Number :3920018, Kawagoe-shi
Investigational Site Number :3920003, Kodaira-shi
Investigational Site Number :3920010, Ōta-ku
Investigational Site Number :3920009, Ube-shi
Investigational Site Number :3920023, Sagamihara-shi
Investigational Site Number :4400001, Vilnius
Investigational Site Number :5280001, Amsterdam
Investigational Site Number :5280003, Breda
Investigational Site Number :5280006, Groningen
Investigational Site Number :5280002, Sittard-Geleen
Investigational Site Number :5780001, Oslo
Investigational Site Number :6160008, Plewiska
Investigational Site Number :6160003, Bydgoszcz
Investigational Site Number :6160005, Warsaw
Investigational Site Number :6160006, Warsaw
Investigational Site Number :6160002, Katowice
Investigational Site Number :6160007, Katowice
Investigational Site Number :6160004, Katowice
Investigational Site Number :6160001, Lodz
Investigational Site Number :6160012, Lublin
Investigational Site Number :6160011, Zabrze
Investigational Site Number :6200001, Braga
Investigational Site Number :6200011, Lisbon
Investigational Site Number :6200007, Lisbon
Investigational Site Number :6200006, Lisbon
Investigational Site Number :6200002, Matosinhos Municipality
Investigational Site Number :6200010, Porto
Investigational Site Number :6420008, Bucharest
Investigational Site Number :7240013, Barcelona
Investigational Site Number :7240016, Barcelona
Investigational Site Number :8040013, Kyiv
Investigational Site Number :8260003, Exeter
Investigational Site Number :8260008, Plymouth
Investigational Site Number :8260010, Swansea
Investigational Site Number :8260012, Nottingham
Investigational Site Number :8260013, Oxford
Investigational Site Number :8260009, Bristol
Investigational Site Number :8260001, Cardiff
Investigational Site Number :8260005, London
Investigational Site Number :8260018, London
Investigational Site Number :8260014, Newcastle upon Tyne
Investigational Site Number :8260019, Salford
Lead Sponsor
Sanofi
INDUSTRY